A Winter's Tale: Report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium

Overview

Journal Can J Cardiol

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2009 Sep 12

PMID 19746243

Authors

Therese Heinonen

David D Waters

Peter Libby

Jean-Claude Tardif

Affiliations

Soon will be listed here.

References

Nissen S, Wolski K . Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007; 356(24):2457-71. DOI: 10.1056/NEJMoa072761. View

Buchwald H, Matts J, Fitch L, Campos C, SANMARCO M, AMPLATZ K . Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group. JAMA. 1992; 268(11):1429-33. View

Azen S, Mack W, Labree L, Shircore A, Selzer R, Blankenhorn D . Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation. 1996; 93(1):34-41. DOI: 10.1161/01.cir.93.1.34. View

Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J . Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke. 2006; 37(3):818-23. DOI: 10.1161/01.STR.0000204638.91099.91. View

Nissen S, Tsunoda T, Tuzcu E, Schoenhagen P, Cooper C, Yasin M . Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003; 290(17):2292-300. DOI: 10.1001/jama.290.17.2292. View

Guedes A, Keller P, LAllier P, LEsperance J, Gregoire J, Tardif J . Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. J Am Coll Cardiol. 2005; 45(4):559-64. DOI: 10.1016/j.jacc.2004.10.063. View

Yabushita H, Bouma B, Houser S, Aretz H, Jang I, Schlendorf K . Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002; 106(13):1640-5. DOI: 10.1161/01.cir.0000029927.92825.f6. View

Cannon C, Braunwald E, McCabe C, Rader D, Rouleau J, Belder R . Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004; 350(15):1495-504. DOI: 10.1056/NEJMoa040583. View

Schaar J, de Korte C, Mastik F, Baldewsing R, Regar E, de Feyter P . Intravascular palpography for high-risk vulnerable plaque assessment. Herz. 2003; 28(6):488-95. DOI: 10.1007/s00059-003-2488-6. View

10.

Rudd J, Myers K, Bansilal S, Machac J, Pinto C, Tong C . Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008; 49(6):871-8. DOI: 10.2967/jnumed.107.050294. View

11.

Stein J, Korcarz C, Hurst R, Lonn E, Kendall C, Mohler E . Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for.... J Am Soc Echocardiogr. 2008; 21(2):93-111. DOI: 10.1016/j.echo.2007.11.011. View

12.

Kastelein J, Akdim F, Stroes E, Zwinderman A, Bots M, Stalenhoef A . Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008; 358(14):1431-43. DOI: 10.1056/NEJMoa0800742. View

13.

Swirski F, Pittet M, Kircher M, Aikawa E, Jaffer F, Libby P . Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci U S A. 2006; 103(27):10340-10345. PMC: 1502459. DOI: 10.1073/pnas.0604260103. View

14.

Garber A . An uncertain future for cardiovascular drug development?. N Engl J Med. 2009; 360(12):1169-71. DOI: 10.1056/NEJMp0808414. View

15.

Berry C, LAllier P, Gregoire J, LEsperance J, Levesque S, Ibrahim R . Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation. 2007; 115(14):1851-7. DOI: 10.1161/CIRCULATIONAHA.106.655654. View

16.

Nissen S, Tardif J, Nicholls S, Revkin J, Shear C, Duggan W . Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007; 356(13):1304-16. DOI: 10.1056/NEJMoa070635. View

17.

Rodriguez-Granillo G, Vaina S, Garcia-Garcia H, Valgimigli M, Duckers E, van Geuns R . Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies. Int J Cardiovasc Imaging. 2006; 22(5):621-31. DOI: 10.1007/s10554-006-9080-0. View

18.

Underhill H, Yuan C, Zhao X, Kraiss L, Parker D, Saam T . Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J. 2008; 155(3):584.e1-8. DOI: 10.1016/j.ahj.2007.11.018. View

19.

Nahrendorf M, Jaffer F, Kelly K, Sosnovik D, Aikawa E, Libby P . Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006; 114(14):1504-11. DOI: 10.1161/CIRCULATIONAHA.106.646380. View

20.

Ballantyne C, Raichlen J, Nicholls S, Erbel R, Tardif J, Brener S . Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation. 2008; 117(19):2458-66. DOI: 10.1161/CIRCULATIONAHA.108.773747. View